Biotech News
-
Valeo Pharma’s Hesperco™ Now Available at Loblaws, Hesperidin Covid-19 Clinical Trial Results Submitted for Publication
Hesperco now available in approximately 300 stores under the Loblaws banners Clinical study yields encouraging results that hesperidin…
-
Sona Announces Appointment of Two New Directors, Debt Settlement and Option Grant
This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated April…
-
Awakn Life Sciences Announces Voluntary Lock-up Agreement Extension with Management, Board of Directors and Key Shareholders
Management, the Board of Directors, and key shareholders represent approximately 11.5 million shares or 46.1% of the issued…
-
Zentek Announces Closing of C$23 Million Bought Deal Public Offering and C$10 Million Non-Brokered Private Placement, for Aggregate Proceeds of C$33 Million
January 4, 2022 (Source) — Zentek Ltd. (TSXV: ZEN) (OTC: ZENYF) (“ZEN” or the “Company”) a Canadian, IP development and…
-
Sixth Wave Announces Closing of Private Placement
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES…
-
Zentek Files Amended and Restated Financial Statements and MD&A, Provides Year End Update on Key Projects and Initiatives, and Amends Terms of Proposed Financing
December 23, 2021 (Source) — Zentek Ltd. (TSXV: ZEN) (OTC: ZENYF) (“ZEN” or the “Company”), a Canadian IP development and…
-
Sixth Wave Announces Non-Brokered Private Placement Financing
August 24, 2020 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave” or the “Company”) is…
-
Element Nutritional Sciences Provides Review of 2021 and Business Outlook
December 16, 2021 (Source) — Element Nutritional Sciences Inc. (CSE:ELMT; OTC:ELNSF; FRANKFURT:93X) (the “Company” or “Element”), is pleased…
-
Awakn Life Sciences Reports Fiscal Third Quarter 2021 Financial Results and Business Highlights
December 15, 2021 (Source) — Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (‘Awakn’), a biotechnology company…
-
DIAGNOS will be Attending in San Francisco during the J.P. Morgan Health Care Conference Week to be held from January 10th to 13th, 2022
December 15, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in…
